/**
 * Industry Acronym Glossary — terms every industry-bound pharmacist should know.
 * Used for the Resource Library glossary card and PDF download.
 */
export const INDUSTRY_GLOSSARY = [
  { term: 'KPI', definition: 'Key Performance Indicator. Metrics used to evaluate success (e.g., number of scientific exchanges, speaker programs completed).' },
  { term: 'KOL', definition: 'Key Opinion Leader. Recognized experts (often physicians or researchers) whose opinions influence clinical practice; MSLs engage KOLs for scientific exchange.' },
  { term: 'Medical Affairs', definition: 'Function that bridges R&D and commercial; responsible for scientific communication, evidence generation, and supporting appropriate use of medicines.' },
  { term: 'MSL', definition: 'Medical Science Liaison. Field-based medical role that provides non-promotional scientific information to HCPs and gathers insights.' },
  { term: 'HCP', definition: 'Healthcare Professional. Physicians, pharmacists, nurses, and other clinicians; primary audience for medical and commercial teams.' },
  { term: 'R&D', definition: 'Research and Development. Discovery, preclinical, and clinical development of drugs and devices.' },
  { term: 'FDA', definition: 'Food and Drug Administration. US regulatory agency that approves drugs and monitors safety and efficacy.' },
  { term: 'EMA', definition: 'European Medicines Agency. EU regulatory body for drug approval and pharmacovigilance.' },
  { term: 'IND', definition: 'Investigational New Drug. Application to FDA to begin clinical trials in humans.' },
  { term: 'NDA', definition: 'New Drug Application. Submission to FDA for approval to market a new drug in the US.' },
  { term: 'BLA', definition: 'Biologics License Application. FDA application for approval of a biologic product.' },
  { term: 'PI', definition: 'Principal Investigator. Lead researcher responsible for conducting a clinical trial at a site.' },
  { term: 'IRB', definition: 'Institutional Review Board. Committee that reviews and approves human research to protect participants.' },
  { term: 'GCP', definition: 'Good Clinical Practice. International ethical and scientific standard for designing and conducting clinical trials.' },
  { term: 'AE', definition: 'Adverse Event. Any untoward medical occurrence in a patient receiving a drug; may or may not be causally related.' },
  { term: 'SAE', definition: 'Serious Adverse Event. Adverse event that results in death, hospitalization, disability, or other serious outcomes.' },
  { term: 'PV', definition: 'Pharmacovigilance. Monitoring and assessing drug safety and adverse events post-approval.' },
  { term: 'MOA', definition: 'Mechanism of Action. How a drug produces its effect at the molecular or cellular level.' },
  { term: 'PK', definition: 'Pharmacokinetics. How the body absorbs, distributes, metabolizes, and excretes a drug.' },
  { term: 'PD', definition: 'Pharmacodynamics. The effects of a drug on the body (e.g., efficacy, receptor binding).' },
  { term: 'RCT', definition: 'Randomized Controlled Trial. Gold-standard clinical study design with random assignment to treatment or control.' },
  { term: 'Real-World Evidence (RWE)', definition: 'Data from real-world settings (EHRs, registries, claims) used to support regulatory and reimbursement decisions.' },
  { term: 'HEOR', definition: 'Health Economics and Outcomes Research. Evaluates clinical, economic, and humanistic value of treatments.' },
  { term: 'QoL', definition: 'Quality of Life. Patient-reported outcomes measuring impact of disease and treatment on daily life.' },
  { term: 'CDP', definition: 'Clinical Development Plan. Strategic plan for clinical trials from Phase I through approval and beyond.' },
  { term: 'TL', definition: 'Territory Lead (or Team Lead). Senior MSL or manager overseeing a region or team.' },
  { term: 'Medical Director', definition: 'Physician or PharmD leading medical strategy, evidence generation, or medical communications for a brand or therapeutic area.' },
  { term: 'Medical Information', definition: 'Function that responds to unsolicited requests for scientific information from HCPs and patients.' },
  { term: 'Medical Education', definition: 'Grants and programs that support independent educational activities for HCPs (often CME).' },
  { term: 'CME', definition: 'Continuing Medical Education. Accredited education for healthcare professionals to maintain competence.' },
  { term: 'Promotional vs Non-Promotional', definition: 'Promotional content is product marketing; MSL interactions are non-promotional and science-focused.' },
  { term: 'Scientific Exchange', definition: 'Two-way dialogue between MSLs and HCPs about disease, treatment, and research; core MSL activity.' },
  { term: 'Insight', definition: 'Feedback or intelligence gathered from HCPs (e.g., unmet needs, practice patterns); reported to internal teams.' },
  { term: 'Speaker Program', definition: 'HCP-led educational programs about a product or disease; company provides grant and materials; must be non-promotional.' },
  { term: 'Ad Board', definition: 'Advisory Board. Meeting with external experts to gather input on strategy, trial design, or medical communications.' },
  { term: 'Congress', definition: 'Major medical conference (e.g., ASCO, ACC, AHA) where data are presented and MSLs engage KOLs.' },
  { term: 'Publication', definition: 'Peer-reviewed manuscript or congress abstract; medical affairs often supports publication plans.' },
  { term: 'Fair Balance', definition: 'Regulatory requirement to present risks and benefits of a product in a balanced way in promotional materials.' },
  { term: 'Off-Label', definition: 'Use of a drug for an indication, population, or dose not in the approved labeling; MSLs can respond to unsolicited questions with scientific data.' },
  { term: 'SOP', definition: 'Standard Operating Procedure. Documented process that teams must follow for compliance and consistency.' },
  { term: 'Compliance', definition: 'Adherence to laws, regulations, and company policies (e.g., PhRMA Code, anti-bribery).' },
  { term: 'PhRMA Code', definition: 'Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals; guides ethical HCP interactions.' },
  { term: 'Sunshine Act', definition: 'US law requiring disclosure of payments and transfers of value to physicians and teaching hospitals.' },
  { term: 'OPDP', definition: 'Office of Prescription Drug Promotion. FDA division that oversees drug advertising and promotion.' },
  { term: 'Sales', definition: 'Commercial function focused on product promotion and revenue; MSLs do not sell.' },
  { term: 'Marketing', definition: 'Brand strategy, campaigns, and messaging; medical provides scientific input and reviews materials.' },
  { term: 'Launch', definition: 'Introduction of a new product to the market; involves medical, commercial, and market access.' },
  { term: 'Market Access', definition: 'Function ensuring patients can obtain and afford treatments (reimbursement, pricing, formulary).' },
  { term: 'Payer', definition: 'Entity that pays for healthcare (e.g., insurance, Medicare, Medicaid).' },
  { term: 'Formulary', definition: 'List of drugs covered by a health plan; market access and HEOR support formulary decisions.' },
  { term: 'ICER', definition: 'Institute for Clinical and Economic Review. Independent organization that evaluates value of new drugs.' },
  { term: 'TA', definition: 'Therapeutic Area. Disease or condition focus (e.g., oncology, cardiology, immunology).' },
  { term: 'Pipeline', definition: 'Company’s portfolio of drugs in development, from discovery through approval.' },
  { term: 'Lifecycle', definition: 'Stages of a product from development through launch, growth, maturity, and eventual decline.' },
  { term: 'Fellowship', definition: 'Structured training program (e.g., industry pharmacy fellowship) to prepare for roles in pharma.' },
  { term: 'Medical Strategy', definition: 'Long-term plan for evidence generation, communication, and medical support for a brand or TA.' },
  { term: 'Evidence Generation', definition: 'Clinical and real-world studies designed to fill data gaps and support product value.' },
  { term: 'Medical Review', definition: 'Process by which medical/regulatory reviewers approve promotional and educational materials for accuracy and compliance.' },
  { term: 'Veeva', definition: 'Common CRM and content management platform used by medical and commercial teams.' },
  { term: 'CRM', definition: 'Customer Relationship Management. System for tracking HCP interactions, call reports, and insights.' },
  { term: 'Call Report', definition: 'Documentation of an MSL or sales interaction with an HCP; required for compliance.' },
  { term: 'Territory', definition: 'Geographic or account-based area assigned to an MSL or sales rep.' },
  { term: 'Cross-Functional', definition: 'Collaboration across departments (e.g., medical, commercial, market access, regulatory).' },
  { term: 'Stakeholder', definition: 'Any person or group with an interest in a project or decision (internal or external).' },
  { term: 'TAE', definition: 'Therapeutic Area Expert. Synonym for KOL in a given disease area.' },
  { term: 'NIH', definition: 'National Institutes of Health. US agency that funds biomedical research; many KOLs have NIH grants.' },
  { term: 'ASHP', definition: 'American Society of Health-System Pharmacists. Major pharmacy organization; relevant for institutional and industry roles.' },
  { term: 'ACCP', definition: 'American College of Clinical Pharmacy. Organization for clinical pharmacists; industry has a presence at ACCP meetings.' },
]

export const GLOSSARY_TITLE = 'Industry Acronym Glossary (Free)'
export const GLOSSARY_SUBTITLE = 'Terms every industry-bound pharmacist should know — PharmacyGuides, LLC'
